Active form of vitamin D analogue mitigates neurodegenerative changes in Alzheimer’s disease in rats by targeting Keap1/Nrf2 and MAPK-38p/ERK signaling pathways

Citation:
El-Dina, S. S., L. Rashed, E. Medhat, B. E. Aboulhoda, A. D. Badawy, A. M. Shamseldeen, and M. Abdelgwad, "Active form of vitamin D analogue mitigates neurodegenerative changes in Alzheimer’s disease in rats by targeting Keap1/Nrf2 and MAPK-38p/ERK signaling pathways", Steroids, vol. 156, pp. 108586, 2020.
Tourism